RPRX Royalty Pharma plc — dividend yield, history & ex-dividend dates
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Dividend Snapshot
Research Scores
Scores describe this security's published financial data on a 0–100 scale using the formulas on our methodology pages. They are the same for every reader, are not a probability or a forecast, and are not a recommendation. Past dividend growth does not guarantee future increases. Report a data error.
How the Dividend Safety Score is built for RPRX
| Input | Value | Points | Weight |
|---|---|---|---|
| Earnings payout ratio | Earnings payout ratio 47% (TTM to Mar 31, 2026) | 93 | 20% |
| FCF payout ratio | N/A (not used) | N/A | 25% |
| Net debt / EBITDA | Net debt / EBITDA 4.9x (TTM to Mar 31, 2026) | 24 | 15% |
| Interest coverage | Interest coverage 5.0x (TTM to Mar 31, 2026) | 66 | 10% |
| Dividend record | 5 years of uninterrupted regular payments | 50 | 20% |
| Earnings stability | Net income positive in 5 of the last 5 fiscal years (FY2021–FY2025) | 100 | 10% |
Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.
How the Dividend Growth Score is built for RPRX
| Input | Value | Points | Weight |
|---|---|---|---|
| 5-year dividend growth | N/A (not used) | N/A | 25% |
| Consecutive annual increases | 4 consecutive annual increases (through 2025) | 52 | 20% |
| Payout headroom | Headroom from the earnings payout ratio 47% (TTM to Mar 31, 2026) | 90 | 20% |
| Earnings per share growth (3 years) | EPS CAGR 162.1% (FY2022–FY2025) | 100 | 15% |
| Revenue growth (3 years) | Revenue CAGR 2.1% (FY2022–FY2025) | 58 | 10% |
| 10-year dividend growth | N/A (not used) | N/A | 10% |
Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.
How the Dividend Value Score is built for RPRX
| Input | Value | Points | Weight |
|---|---|---|---|
| Yield vs own history | Current yield at the 2nd percentile of its 60 month-end yields | 2 | 40% |
| P/E vs own 5-year median | P/E 41.2 is 2.37x its 5-year median of 17.4 | 0 | 25% |
| FCF yield | N/A (not used) | N/A | 20% |
| P/E vs peers | P/E 41.2 vs peer median 26.9 (1.53x; 45 corporation / Healthcare securities) | 5 | 15% |
Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.
Key Metrics
Current Yield
1.54%
At the Oct 19, 2026 price
The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.Annualized Dividend
$0.9400
Declared Oct 16, 2026
The latest declared regular dividend scaled to a full year by how often it's paid (for semi-annual payers, the latest two payments), adjusted for stock splits. A $0.25 quarterly dividend annualizes to $1.00. Special dividends are excluded.Frequency
Q Quarterly
How often the dividend is paid, read from the dates of recent payments: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.RSI (14)
59
As of Oct 19, 2026
Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.52-Week Range
$36.34 – $63.96
Closes through Oct 16, 2026
The lowest and highest price over the past year, showing where today's price sits in its recent range.Payout Ratio (TTM)
48.95%
12 months to Jun 30, 2026 (Q2 FY2026)
The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.Years Paying
6
How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.Price / Book (TTM)
3.97
Price as of Oct 18, 2026; latest reported book value
Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.S.A.F.E. Dividend Read
Quote & Key Data
Dividend Growth
Why the Yield Moved (90 Days)
RPRX's dividend yield fell from 1.61% to 1.54% over the past ~90 days (-0.07 pp). Of that move, +0.00 pp came from changes in the dividend rate and -0.07 pp from the share price ($58.42 on Jul 21, 2026 → $60.96 on Oct 19, 2026). A yield that rises because the price fell is not an improvement in the payout itself.
Yield vs Its Own History
Across 275 daily observations over the past 13 months (through Oct 16, 2026), RPRX's current yield is higher than approximately 4% of them. Our stored price history for RPRX covers the past 13 months; 3- and 5-year averages are not yet computable from it and are deliberately not shown.
Adjusted Price History
Dividend History
Dividend Payment History
Ex-dividend calendar →| Amount | Type | Declared | Ex-Date | Record | Pay |
|---|---|---|---|---|---|
| $0.2350 Q | Regular upcoming, declared | Oct 16, 2026 | Nov 13, 2026 | Nov 13, 2026 | Dec 10, 2026 |
| $0.2350 Q | Regular | Jul 17, 2026 | Aug 14, 2026 | Aug 14, 2026 | Sep 10, 2026 |
| $0.2350 Q | Regular | Apr 17, 2026 | May 15, 2026 | May 15, 2026 | Jun 10, 2026 |
| $0.2350 Q | Regular | Jan 09, 2026 | Feb 20, 2026 | Feb 20, 2026 | Mar 10, 2026 |
| $0.2200 Q | Regular | Oct 17, 2025 | Nov 14, 2025 | Nov 14, 2025 | Dec 10, 2025 |
| $0.2200 Q | Regular | Jul 18, 2025 | Aug 15, 2025 | Aug 15, 2025 | Sep 10, 2025 |
| $0.2200 Q | Regular | Apr 21, 2025 | May 16, 2025 | May 16, 2025 | Jun 10, 2025 |
| $0.2200 Q | Regular | Jan 09, 2025 | Feb 21, 2025 | Feb 21, 2025 | Mar 10, 2025 |
| $0.2100 Q | Regular | Oct 11, 2024 | Nov 15, 2024 | Nov 15, 2024 | Dec 10, 2024 |
| $0.2100 Q | Regular | Jul 17, 2024 | Aug 16, 2024 | Aug 16, 2024 | Sep 13, 2024 |
| $0.2100 Q | Regular | Apr 17, 2024 | May 16, 2024 | May 17, 2024 | Jun 14, 2024 |
| $0.2100 Q | Regular | Jan 19, 2024 | Feb 15, 2024 | Feb 16, 2024 | Mar 15, 2024 |
| $0.2000 Q | Regular | Oct 16, 2023 | Nov 16, 2023 | Nov 17, 2023 | Dec 15, 2023 |
| $0.2000 Q | Regular | Jul 17, 2023 | Aug 17, 2023 | Aug 18, 2023 | Sep 15, 2023 |
| $0.2000 Q | Regular | Apr 17, 2023 | May 18, 2023 | May 19, 2023 | Jun 15, 2023 |
| $0.2000 Q | Regular | Jan 09, 2023 | Feb 15, 2023 | Feb 16, 2023 | Mar 15, 2023 |
| $0.1900 Q | Regular | Oct 17, 2022 | Nov 17, 2022 | Nov 18, 2022 | Dec 15, 2022 |
| $0.1900 Q | Regular | Jul 15, 2022 | Aug 18, 2022 | Aug 19, 2022 | Sep 15, 2022 |
| $0.1900 Q | Regular | Apr 18, 2022 | May 19, 2022 | May 20, 2022 | Jun 15, 2022 |
| $0.1900 Q | Regular | Jan 06, 2022 | Feb 17, 2022 | Feb 18, 2022 | Mar 15, 2022 |
| $0.1700 Q | Regular | Oct 15, 2021 | Nov 18, 2021 | Nov 19, 2021 | Dec 15, 2021 |
| $0.1700 Q | Regular | Jul 16, 2021 | Aug 19, 2021 | Aug 20, 2021 | Sep 15, 2021 |
| $0.1700 Q | Regular | Apr 15, 2021 | May 19, 2021 | May 20, 2021 | Jun 15, 2021 |
| $0.1700 Q | Regular | Jan 08, 2021 | Feb 18, 2021 | Feb 19, 2021 | Mar 15, 2021 |
| $0.1500 Q | Regular | Oct 15, 2020 | Nov 19, 2020 | Nov 20, 2020 | Dec 15, 2020 |
| $0.1500 Q | Special | Sep 02, 2020 | Sep 14, 2020 | Sep 15, 2020 | Sep 30, 2020 |
Peer Comparison
Selected Medical - Pharmaceuticals dividend payers we cover, strongest DividendRank first — for context, not a recommendation.
| Ticker | Name | Yield | 5-Yr Growth | Streak | Rank |
|---|---|---|---|---|---|
| SGIPF | Sugi Holdings Co.,Ltd. | 2.34% | -1.3% | 2 yrs | 71 |
Related Guides & Lists
RPRX dividend — frequently asked questions
Does Royalty Pharma plc pay a dividend?
Yes. Royalty Pharma plc (RPRX) currently pays a dividend. The annualized dividend is about $0.94 per share, a yield of approximately 1.54%.
What is Royalty Pharma plc's dividend yield?
Royalty Pharma plc's dividend yield is approximately 1.54%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.
How often does Royalty Pharma plc pay dividends?
Royalty Pharma plc pays dividends quarterly — 4 times per year.
When is Royalty Pharma plc's next ex-dividend date?
The next declared ex-dividend date for Royalty Pharma plc is November 13, 2026. The associated payment is $0.2350 per share; you must own the shares before the ex-dividend date to receive it.
How long has Royalty Pharma plc paid dividends?
Royalty Pharma plc has 6 years of dividend payments on record, and has increased its dividend for 4 consecutive years.
Data updated Oct 19, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.